The analyses were performed using post-mortem matched brain tissues from unaffected individuals to directly assess the genetic contribution to the regulation of SNCA expression, avoiding other confounding factors arising from the neurodegeneration associated with PD. This evidence concerns the gene SNCA and Parkinson disease.